STAT News

Opinion: Why the FDA should not approve an ineffective multicancer screening test

“Telling more people they have cancer is not progress; progress is having fewer people die from cancer,” H. Gilbert Welch writes of Grail’s multicancer screening test.

By STAT News

1 min read
Opinion: Why the FDA should not approve an ineffective multicancer screening test
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights